Robyn L. Phelps
BS, MSc, PhD
PhD, Cardiovascular Physiology, Univ. of British Columbia, 1995 MSc, Cardiovascular Dynamics, Univ. of North Carolina, 1990 BSc, Physiology, Michigan State University, 1979
Carcinogenicity, Cardiovascular Toxicology, Consumer Products, Dermal Toxicology, Drug/Pharmaceutical Development, Formulations, Genetic Toxicology and Cytogenetics, GLP Study Auditing, Medical Devices, Ocular Toxicology, Over-The Counter Products, Pharmacokinetics/Toxicokinetics, Product Safety Assessment, Regulatory Toxicology, Risk Assessment, Safety Pharmacology
Program development and nonclinical strategy guidance for drug and device programs Knowledgeable of worldwide regulations and experienced in global agency interactions Excellent writer; INDs, IMPDs, NDAs and MAAs; scientific publications and presentations Toxicologist; all administration routes with extensive experience in Dermal and Ocular drug development Safety Pharmacologist; cardiopulmonary and CNS focus Specialized in nonclinical model design and development for targeted delivery therapies Experienced technical and compliance monitor for nonclinical programs
More than 30 years experience in toxicology and nonclinical drug safety evaluation, safety pharmacology, and physiology/model development. Experienced scientist and nonclinical program director in global pharmaceutical development, industrial and contract research companies. Author of nonclinical sections of INDs, NDAs, MAAs, IBs, technical assessments, manuscripts, and book chapters. Corporate Scientific Advisor, Cardiovascular Research.
PharmAdvance Consulting, Inc
2442 Lost Mountain Rd